生物活性 | |||
---|---|---|---|
描述 | Histone deacetylases (HDAC) are responsible for the deacetylation of lysine residues on both histone and non-histone proteins. HDAC6 belongs to class IIB HDAC. HDAC6 inhibitors are expected to possess therapeutic potential in oncology, immunology, and neurology. CG347B is a selective HDAC6 inhibitor, which also involves I synthesis of other metalloenzyne inhibitors[1]. In NCI-H460/CDDP cells, treatment with CG347B did not significantly alter the expression of high temperature requirement factor serine peptidase 1 at either mRNA or protein levels[2]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
3.53mL 0.71mL 0.35mL |
17.65mL 3.53mL 1.76mL |
35.30mL 7.06mL 3.53mL |
参考文献 |
---|
[1]Christopher M. Yates. Metalloenzyme inhibitor compounds. Google Patnets. 2018. |